A clinical trial involving BPC-157 has reached completed status as of August 7, 2026. The study, registered as NCT07752381, is titled "A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery." The trial phase is listed as not applicable.
According to the registry entry, the study examined peptide gummies in relation to markers of inflammation, physical performance, and recovery. The status update indicates the trial has finished, but no results have been reported in this update. BPC-157 remains classified as an unapproved compound used only in research settings.
This update reflects the trial's status change only. No outcome data, efficacy claims, or safety findings are included in this event record. Readers should not interpret the completed status as an indication of results or conclusions from the study.
Further detail on the trial design, sponsor, and eventual results, if posted, would appear in future updates to the same registry listing. For more background on this compound, see the linked compound overview.</body_markdown>
<parameter name="sources">["https://clinicaltrials.gov/study/NCT07752381"]